Vaxcyte, Inc 10-Q for FY2023 Q2
Vaxcyte, Inc. (PCVX)
10-Q
2023-08-08
For: 2023-06-30
View Original
Added on
April 07, 2026
About this 10-Q
Vaxcyte, Inc filed this 10-Q on August 8, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).
Headline figures
Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $68.34M
- compared with a net loss of $48.53M a year earlier
- Diluted EPS
- -$0.70
- compared with -$0.80 a year earlier